Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site von DeGrendele, Heather C., Estess, Pila, Siegelman, Mark H.

Volltext

Activation and interaction of CD44 and hyaluronan in immunological systems von Siegelman, Mark H., DeGrendele, Heather C., Estess, Pila

Volltext

CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway von DeGrendele, H C, Estess, P, Picker, L J, Siegelman, M H

Volltext

CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation von DeGrendele, HC, Kosfiszer, M, Estess, P, Siegelman, MH

Volltext

Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity von Estess, P, DeGrendele, H C, Pascual, V, Siegelman, M H

Volltext

Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002 von Maung, Kavita, Lee, David, DeGrendele, Heather C, Schilsky, Richard, Chu, Edward, Jain, Vinay K, Copur, Sitki

Volltext

Highlights From: 39th Annual Meeting of the American Society of Clinical Oncology; Chicago, Illinois May 31 to June 3, 2003 von DeGrendele, Heather C., Gibson, Angelia D., Marshall, John, Chu, Edward

Volltext

Highlights From: 27 th Congress of the European Society for Medical Oncology Nice, France October 18–22, 2002 von Maung, Kavita, Lee, David, DeGrendele, Heather C., Schilsky, Richard, Chu, Edward, Jain, Vinay K., Copur, M. Sitki

Volltext

Epidermal Growth Factor Receptor Inhibitors, Gefitinib and Erlotinib (Tarceva™, OSI-774), in the Treatment of Bronchioloalveolar Carcinoma von DeGrendele, Heather, Belani, Chandra P., Perry, Michael C.

Volltext

Cell-Cycle Inhibitors as Novel Therapies for Lung Cancer von DeGrendele, Heather, Belani, Chandra P., Shapiro, Geoffrey, Perry, Michael C.

Volltext